Physician profile
Jonathan Moss
NPI 1295394294
$15,788.24
in general payments reported to CMS, 2019-2025
34 companies · $1,399 in 2025
The $1,399 reported for 2025 was more than what 76% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,349 · 2020: $939 · 2021: $3,151 · 2022: $5,614 · 2023: $1,905 · 2024: $1,433 · 2025: $1,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,410 · Travel and Lodging: $2,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,409.84 |
| Travel and Lodging | $2,326.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $5,726.57 | 2019-2023 | |
| Stryker Corporation | $3,913.60 | 2021-2025 | Hoffmann, Citrefix, Augment Injectable |
| Orthofix Medical, INC. | $2,264.25 | 2019-2022 | |
| Treace Medical Concepts, INC. | $708.32 | 2022-2023 | |
| Mimedx Group, INC. | $442.41 | 2024-2025 | |
| Arthrex, INC. | $392.80 | 2023 | |
| Integra Lifesciences Corporation | $274.26 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $248.50 | 2020-2022 | |
| Medtronic, INC. | $185.14 | 2025 | Hawkone, Venaseal |
| Paragon 28, INC. | $174.74 | 2020-2024 | Portfolio |
| Smith+Nephew, INC. | $155.75 | 2019-2023 | Collagenase Santyl |
| Kerecis Limited | $142.14 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Angiodynamics, INC. | $126.75 | 2021 | |
| Horizon Therapeutics Plc | $124.99 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $124.87 | 2023 | Farxiga |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $114.47 | 2019 | |
| Bioventus LLC | $80.00 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $72.29 | 2021 | |
| Averitas Pharma INC. | $70.18 | 2025 | Qutenza |
| Globus Medical, INC. | $66.62 | 2021 | |
| Nexus Medical Technologies LLC | $58.07 | 2025 | |
| Grt US Holding, INC. | $42.81 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $39.99 | 2022-2023 | |
| Polynovo North America LLC | $37.57 | 2023 | |
| Abbvie INC. | $35.02 | 2022-2023 | |
| Solventum Corporation | $34.25 | 2024-2025 | Activ.A.C., Activ.A.C. Ion Progress, Snap |
| Arteriocyte Medical Systems, INC. | $29.16 | 2021 | |
| Abbott Laboratories | $22.96 | 2024 | Eterna |
| Heron Therapeutics, INC. | $16.18 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $13.75 | 2020 | |
| Amgen INC. | $13.62 | 2025 | Krystexxa |
| Boston Scientific Corporation | $13.40 | 2019 | |
| Paratek Pharmaceuticals, INC. | $11.90 | 2022 | |
| Acell, INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.